Schneider, Pauline
Crump, Nicholas T.
Arentsen-Peters, Susan T.C.J.M.
Smith, Alastair L.
Hagelaar, Rico
Adriaanse, Fabienne R.S.
Bos, Romy S.
de Jong, Anja
Nierkens, Stefan
Koopmans, Bianca
Milne, Thomas A.
Pieters, Rob
Stam, Ronald W.
Funding for this research was provided by:
Stichting Kinderen Kankervrij
Kay Kendall Leukaemia Fund (KKL1443)
Medical Research Council (Unit grants MC_UU_00016/6 and MC_UU_00029/6, Unit grants MC_UU_00016/6 and MC_UU_00029/6)
Article History
Received: 9 August 2023
Accepted: 11 September 2023
First Online: 22 September 2023
Declarations
:
: T.A.M. and N.T.C. are paid consultants for and shareholders in Dark Blue Therapeutics Ltd. The other authors declare no competing financial interests.